The therapeutic effectiveness of neostigmine in myasthenia gravis is due to

A、its ability to protect the muscle endplate against acetylcholine;
B、its ability to increase the rate of ACh synthesis;
C、 its ability to inhibit acetylcholinesterase (AChE);
D、its ability to inactivate N៳ receptors;
E、its action on cardiovascular system